Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pharmaceutical Supply Chain Risk Assessment in Iran Using Analytic Hierarchy Process (Ahp) and Simple Additive Weighting (Saw) Methods Publisher



Jaberidoost M1 ; Olfat L2 ; Hosseini A3 ; Kebriaeezadeh A1, 4 ; Abdollahi M1, 4 ; Alaeddini M5 ; Dinarvand R1, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran University of Medical Sciences, Tehran, 1417614411, Iran
  2. 2. Management Department, Allame Tabatabaei University, Tehran, Iran
  3. 3. Food and Drug Organization, Ministry of Health and Medical Education, Tehran, Iran
  4. 4. Department of Toxicology and Pharmacology, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Industrial Engineering, University of Science and Culture, Tehran, Iran
  6. 6. Department of Pharmaceutics, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Pharmaceutical Policy and Practice Published:2015


Abstract

Objectives: Pharmaceutical supply chain is a significant component of the health system in supplying medicines, particularly in countries where main drugs are provided by local pharmaceutical companies. No previous studies exist assessing risks and disruptions in pharmaceutical companies while assessing the pharmaceutical supply chain. Any risks affecting the pharmaceutical companies could disrupt supply medicines and health system efficiency. The goal of this study was the risk assessment in pharmaceutical industry in Iran considering process's priority, hazard and probability of risks. Methods: The study was carried out in 4 phases; risk identification through literature review, risk identification in Iranian pharmaceutical companies through interview with experts, risk analysis through a questionnaire and consultation with experts using group analytic hierarchy process (AHP) method and rating scale (RS) and risk evaluation of simple additive weighting (SAW) method. Results: In total, 86 main risks were identified in the pharmaceutical supply chain with perspective of pharmaceutical companies classified in 11 classes. The majority of risks described in this study were related to the financial and economic category. Also financial management was found to be the most important factor for consideration. Conclusion: Although pharmaceutical industry and supply chain were affected by current political conditions in Iran during the study time, but half of total risks in the pharmaceutical supply chain were found to be internal risks which could be fixed by companies, internally. Likewise, political status and related risks forced companies to focus more on financial and supply management resulting in less attention to quality management. © 2015 Jaberidoost et al.; licensee BioMed Central.
Related Docs
1. Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran, Pharmaceutical Sciences (2021)
Experts (# of related papers)
Shekoufeh Nikfar (1)
Akbar Abdollahi-Asl (1)